These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32041760)

  • 21. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
    Cuadrado MJ; Bertolaccini ML; Seed PT; Tektonidou MG; Aguirre A; Mico L; Gordon C; Ruiz-Irastorza G; Egurbide MV; Gil A; Espinosa G; Houssiau F; Rahman A; Martin H; McHugh N; Galindo M; Akil M; Amigo MC; Murru V; Khamashta MA
    Rheumatology (Oxford); 2014 Feb; 53(2):275-84. PubMed ID: 24097288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.
    Rosove MH; Brewer PM
    Ann Intern Med; 1992 Aug; 117(4):303-8. PubMed ID: 1637025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease.
    Reid JD; Bressler B; English J
    Can Respir J; 2011; 18(5):262-4. PubMed ID: 21969926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probable diffuse retinopathy caused by adalimumab in a patient with Crohn's disease.
    Marticorena-Álvarez P; Chaparro M; Pérez-Casas A; Muriel-Herrero A; Gisbert JP
    J Crohns Colitis; 2012 Oct; 6(9):950-3. PubMed ID: 22537636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments.
    Rivier G; Herranz MT; Khamashta MA; Hughes GR
    Lupus; 1994 Apr; 3(2):85-90. PubMed ID: 7920619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary actinomycosis coexisting with intestinal tuberculosis as a complication of adalimumab treatment for Crohn's disease.
    Aleric I; Katalinic D; Vcev A; Brinar M
    Acta Gastroenterol Belg; 2017; 80(4):544-546. PubMed ID: 29560655
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute kidney injury caused by COVID-19 in a patient with Crohn's disease treated with adalimumab.
    Lenti MV; Gregorini M; Borrelli de Andreis F; Rampino T; D'Ambrosio G; Verga L; Vanoli A; Mengoli C; Ravetta V; Paulli M; Di Sabatino A
    J Clin Pathol; 2021 Aug; 74(8):540-542. PubMed ID: 32820044
    [No Abstract]   [Full Text] [Related]  

  • 28. Arterial thromboembolism from a distal aortic thrombus in a patient with Crohn's disease.
    Lehmann JM; Shnaker A; Silverberg D; Dayan K; Witz M
    Isr Med Assoc J; 2001 Mar; 3(3):226-7. PubMed ID: 11303385
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease.
    Ogata H; Watanabe M; Matsui T; Hase H; Okayasu M; Tsuchiya T; Shinmura Y; Hibi T
    J Crohns Colitis; 2016 Sep; 10(9):1033-41. PubMed ID: 26961546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vogt-Koyanagi-Harada Disease and Systemic Lupus Erythematosus Occurring during Adalimumab Therapy for Ulcerative Colitis.
    AlBloushi AF; Al-Hadlaq OS; AlRashed FA; Abu El-Asrar AM
    Middle East Afr J Ophthalmol; 2020; 27(3):185-187. PubMed ID: 33488017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digital gangrene in systemic lupus erythematosus.
    Nagai Y; Shimizu A; Suto M; Tanaka S; Yasuda M; Tago O; Hasegawa M; Ishikawa O
    Acta Derm Venereol; 2009; 89(4):398-401. PubMed ID: 19688154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteonecrosis of the jaw in a Crohn's disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report.
    Preidl RH; Ebker T; Raithel M; Wehrhan F; Neukam FW; Stockmann P
    BMC Gastroenterol; 2014 Jan; 14():6. PubMed ID: 24400722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
    Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
    [No Abstract]   [Full Text] [Related]  

  • 34. [Subacute meningococcaemia during adalimumab therapy].
    Salinas N; Etienne M; Roguedas AM; Le Flahec G; Misery L
    Ann Dermatol Venereol; 2019 Dec; 146(12):817-820. PubMed ID: 31648846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
    Casanova MJ; Chaparro M; Martínez S; Vicuña I; Gisbert JP
    J Crohns Colitis; 2012 Dec; 6(10):1034-7. PubMed ID: 22534313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
    Miranda-Bautista J; Menchén L
    Gastroenterol Hepatol; 2019 May; 42(5):306-307. PubMed ID: 30029925
    [No Abstract]   [Full Text] [Related]  

  • 37. Antiphospholipid antibody syndrome-associated renal thrombotic microangiopathy improved not with rivaroxaban but with warfarin in a systemic lupus erythematosus patient without lupus nephritis.
    Horita S; Zoshima T; Hara S; Koichi M; Hirayama S; Suzuki K; Nakashima A; Kawano M
    CEN Case Rep; 2021 Aug; 10(3):409-413. PubMed ID: 33595828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adalimumab for the treatment of pediatric Crohn's disease.
    Nuti F; Fiorino G; Danese S
    Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nephrotic syndrome in Crohn's disease].
    Boiten HJ; Honkoop P; Smak Gregoor PJ
    Ned Tijdschr Geneeskd; 2015; 159():A9264. PubMed ID: 26306485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adalimumab as a potential cause of drug-induced thrombocytopaenic microangiopathy.
    Falsetti L; Sampaolesi M; Riccomi F; Nitti C
    BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32139450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.